These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 20147975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X, Inukai T, Hirose K, Akahane K, Kuroda I, Honna-Oshiro H, Kagami K, Goi K, Nakamura K, Kobayashi M, Endo M, Yagita H, Kurosawa H, Thomas Look A, Honda H, Inaba T, Nakazawa S, Sugita K.
    Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J, Kempski H, Neat M, Bailey S, Smith O, Brady HJ.
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [Abstract] [Full Text] [Related]

  • 5. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M, Prima V, Tung YH, Hunger SP.
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [Abstract] [Full Text] [Related]

  • 6. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
    Hirose K, Inukai T, Kikuchi J, Furukawa Y, Ikawa T, Kawamoto H, Oram SH, Göttgens B, Kiyokawa N, Miyagawa Y, Okita H, Akahane K, Zhang X, Kuroda I, Honna H, Kagami K, Goi K, Kurosawa H, Look AT, Matsui H, Inaba T, Sugita K.
    Blood; 2010 Aug 12; 116(6):962-70. PubMed ID: 20519628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
    Hunger SP, Brown R, Cleary ML.
    Mol Cell Biol; 1994 Sep 12; 14(9):5986-96. PubMed ID: 8065331
    [Abstract] [Full Text] [Related]

  • 11. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
    Panagopoulos I, Micci F, Thorsen J, Haugom L, Tierens A, Ulvmoen A, Heim S.
    Cancer Genet; 2012 Dec 12; 205(12):669-72. PubMed ID: 23181981
    [Abstract] [Full Text] [Related]

  • 12. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A, Thomas M, Castro PG, Büchler L, Scholz A, Brümmendorf TH, Soria NM, Vormoor J, Greil J, Heidenreich O.
    Leukemia; 2010 Oct 12; 24(10):1751-9. PubMed ID: 20686504
    [Abstract] [Full Text] [Related]

  • 13. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
    Duque-Afonso J, Smith KS, Cleary ML.
    PLoS One; 2015 Oct 12; 10(11):e0143216. PubMed ID: 26588248
    [Abstract] [Full Text] [Related]

  • 14. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
    Abdelhaleem M.
    Exp Mol Pathol; 2007 Aug 12; 83(1):138-41. PubMed ID: 17434163
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
    Raponi S, De Propris MS, Intoppa S, Milani ML, Vitale A, Elia L, Perbellini O, Pizzolo G, Foá R, Guarini A.
    Leuk Lymphoma; 2011 Jun 12; 52(6):1098-107. PubMed ID: 21348573
    [Abstract] [Full Text] [Related]

  • 16. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia.
    Siraj AK, Ozbek U, Sazawal S, Sirma S, Timson G, Al-Nasser A, Bhargava M, El Solh H, Bhatia K, Gutiérrez MI.
    Clin Cancer Res; 2002 Dec 12; 8(12):3832-40. PubMed ID: 12473597
    [Abstract] [Full Text] [Related]

  • 17. MLL/AF-4 leukemic cells recruit new blood vessels but do not incorporate into capillaries in culture or in a NOD/SCID xenograft model.
    Hu Z, Li XM, Jorgensen ML, Slayton WB.
    Leukemia; 2009 May 12; 23(5):990-3. PubMed ID: 19158831
    [No Abstract] [Full Text] [Related]

  • 18. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.
    Inukai T, Hirose K, Inaba T, Kurosawa H, Hama A, Inada H, Chin M, Nagatoshi Y, Ohtsuka Y, Oda M, Goto H, Endo M, Morimoto A, Imaizumi M, Kawamura N, Miyajima Y, Ohtake M, Miyaji R, Saito M, Tawa A, Yanai F, Goi K, Nakazawa S, Sugita K.
    Leukemia; 2007 Feb 12; 21(2):288-96. PubMed ID: 17183364
    [Abstract] [Full Text] [Related]

  • 19. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J, Hotfilder M, Rosemann A, Langebrake C, Reinhardt D, Pieters R, Schrauder A, Schrappe M, Röttgers S, Harbott J, Vormoor J.
    Br J Haematol; 2006 May 12; 133(3):337-44. PubMed ID: 16643437
    [Abstract] [Full Text] [Related]

  • 20. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP, Li S, Fall MZ, Naumovski L, Cleary ML.
    Blood; 1996 Jun 01; 87(11):4607-17. PubMed ID: 8639829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.